Skip to content

Premature Rupture of Mambrane and Unfavourable Cervix

Comparison Between the Use of Standard Oxytocin Induction Protocol and the Double-balloon Catheter Device With Concurrent Oxytocin

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01615107
Enrollment
300
Registered
2012-06-08
Start date
2012-07-31
Completion date
2014-07-31
Last updated
2012-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervix; Insufficient Dilatation in Labor

Brief summary

The paucity of published data concerning the issue of mechanical labor induction in the setting of Term PROM has led us to undertake the present clinical trial. This study is designed to compare the efficacy and safety of the standard Oxytocin induction protocol with the double-balloon catheter device with concurrent oxytocin administration in patients with Term PROM and unfavorable cervical conditions.

Detailed description

This will be a prospective randomised trial. Two hundred pregnant women with term PROM and an unfavourable cervix (Bishop Score ≤ 4) are expected to be entered into the study (see statistical analysis below). All eligible women will be presented with the study protocol by a study coordinator. Women interested in participating will read and sign the informed consent. Subsequently, the following screening medical procedures will be completed: medical and gynecological history, physical and vaginal examination, ultrasonography to: (i) Confirm fetal vertex presentation, (ii) Exclude placenta previa and (iii) Assess cervical length and posterior cervical angle. (iv) Asses bio-physical profile score A non-stress test will be performed in order to monitor: 1. The fetal heart pattern for the presence or absence of decelerations and 2. The presence of uterine contractions. All women will undergo a pelvic examination by a staff member to obtain an initial Bishop score. If the patient will be determined eligible for study entry, and following the informed consent, randomisation into the following groups will take place: GROUP 1: Oxytocin infusion alone (Standard Protocol). GROUP 2: insertion of the double balloon device and concurrent oxytocin administration. GROUP 3: Expectant management

Interventions

DEVICECOOK RIPENENIG BALLOON+PITOCN

GROUP 2: insertion of the double balloon device and concurrent oxytocin administration.

: Oxytocin infusion alone (Standard Protocol

OTHERdouble balloonand oxytocin

balloonand oxytocin

OTHERballon and oxytocin

double- balloon catheter device with concurrent oxytocin

PROCEDUREdouble balloonand and oxytocin

balloon catheter device with concurrent oxytocin

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Diagnosed to be pregnant with PROM at \> 34 week 2. Found to have a Bishop score of 4 points or less. 3. Diagnosed as having a singleto 4. Willingness to comply with the protocol for the duration of the study. 5. Have signed an informed consent.

Exclusion criteria

1. Any contraindication for a vaginal deliver 2. Regular uterine contractn 3. Evidence of chorio-amonitis 4. Previous cesarean section or presence of any uterine scar. 5. Suspected placental abruption or presence of a significant hemorrhage. 6. Non-reassuring fetal statu

Design outcomes

Primary

MeasureTime frameDescription
PPROM/PROM to delivery interval3yearTime from rupture of mambrane to delivery From hospitalization until delivery

Countries

Israel

Contacts

Primary ContactElad Mei-Dan, Dr
972-4-6188243

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026